Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S de Bono

Showing results (41-50 of 492) with videos related to

Pageof 50
Sort By:
British Journal of Cancer|January 6, 2011
Targeting IGF-1R: throwing out the baby with the bathwater?B Basu, D Olmos, J S de Bono
Drugs|May 25, 2012
Management of metastatic castration-resistant prostate cancer: recent advancesDeborah Mukherji, Andrew Eichholz, Johann S De Bono
European Urology|February 25, 2017
Investigating Genomic Aberrations of the Androgen Receptor: Moving Closer to More Precise Prostate Cancer Care?Joaquin Mateo, Adam Sharp, Johann S de Bono
The Journal of Hospital Infection|December 7, 2013
Organizational culture and its implications for infection prevention and control in healthcare institutionsS De Bono, G Heling, M A Borg
JAMA Oncology|January 1, 2016
Chemical or Surgical Castration--Is This Still an Important Question?Michael Kolinsky, Pasquale Rescigno, Johann S de Bono
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Molecular characterization and clinical utility of circulating tumor cells in the treatment of prostate cancerDavid Lorente, Joaquin Mateo, Johann S de Bono
BJU International|December 22, 2016
Circulating biomarkers of neuroendocrine prostate cancer: an unmet challengePasquale Rescigno, Daniel Nava Rodrigues, Johann S de Bono
European Urology|March 6, 2025
T-Cell Engagers in Prostate Cancer: Promise, Challenges, and the Road AheadTarek Taha, Kira-Lee Koster, Johann S de Bono
BJU International|November 17, 2005
Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancerGerhardt Attard, Arie S Belldegrun, Johann S de Bono
JAMA Oncology|June 30, 2018
Nuclear Circulating Tumor Cell Androgen Receptor Variant 7 in Castration-Resistant Prostate Cancer: The Devil Is in the DetailStephen R Plymate, Adam Sharp, Johann S de Bono
Pageof 50

Showing results (41-50 of 492) with videos related to

Sort By:
Pageof 50
British Journal of Cancer|January 6, 2011
Targeting IGF-1R: throwing out the baby with the bathwater?B Basu, D Olmos, J S de Bono
Drugs|May 25, 2012
Management of metastatic castration-resistant prostate cancer: recent advancesDeborah Mukherji, Andrew Eichholz, Johann S De Bono
European Urology|February 25, 2017
Investigating Genomic Aberrations of the Androgen Receptor: Moving Closer to More Precise Prostate Cancer Care?Joaquin Mateo, Adam Sharp, Johann S de Bono
The Journal of Hospital Infection|December 7, 2013
Organizational culture and its implications for infection prevention and control in healthcare institutionsS De Bono, G Heling, M A Borg
JAMA Oncology|January 1, 2016
Chemical or Surgical Castration--Is This Still an Important Question?Michael Kolinsky, Pasquale Rescigno, Johann S de Bono
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Molecular characterization and clinical utility of circulating tumor cells in the treatment of prostate cancerDavid Lorente, Joaquin Mateo, Johann S de Bono
BJU International|December 22, 2016
Circulating biomarkers of neuroendocrine prostate cancer: an unmet challengePasquale Rescigno, Daniel Nava Rodrigues, Johann S de Bono
European Urology|March 6, 2025
T-Cell Engagers in Prostate Cancer: Promise, Challenges, and the Road AheadTarek Taha, Kira-Lee Koster, Johann S de Bono
BJU International|November 17, 2005
Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancerGerhardt Attard, Arie S Belldegrun, Johann S de Bono
JAMA Oncology|June 30, 2018
Nuclear Circulating Tumor Cell Androgen Receptor Variant 7 in Castration-Resistant Prostate Cancer: The Devil Is in the DetailStephen R Plymate, Adam Sharp, Johann S de Bono
Pageof 50